manufacturing defects – Pharma.Tips

CCIT failure during packaging – regulatory risk assessment

Regulatory Risk Assessment of CCIT Failures During Packaging In the fast-paced world of pharmaceutical manufacturing, the failure of container closure integrity testing (CCIT) during the packaging process can pose significant…

Viscosity variation during storage – QA investigation failure

Investigation of Viscosity Variations During Storage in Pharmaceuticals Viscosity variation during storage is a frequent issue observed in pharmaceutical manufacturing, particularly with suspensions and syrups. Such nonconformance can prompt Out…

Phase separation after temperature excursion – QA investigation failure

Investigating Phase Separation After Temperature Excursion: A Comprehensive QA Approach In the world of pharmaceutical manufacturing, deviations from established protocols can lead to significant quality concerns and product failures. One…

Tube leakage after packaging change – inspection readiness risk

Investigating Tube Leakage Issues Following Packaging Change: Ensuring Inspection Readiness In the fast-paced world of pharmaceutical manufacturing, packaging changes are a common necessity. However, they can also introduce significant risks,…

pH drift on storage at accelerated conditions – stability investigation failure

Stability Investigation of pH Drift During Storage at Accelerated Conditions Issues related to pH drift during storage at accelerated conditions represent significant risks in pharmaceutical manufacturing. Such deviations can result…

Physical appearance change during shelf-life extension – stability investigation failure

Stability Investigation Failures: Addressing Physical Appearance Changes During Shelf-Life Extension The occurrence of physical appearance changes during the shelf-life extension of pharmaceutical products can indicate underlying issues that may lead…

Impurity increase during shelf-life extension – CAPA and shelf-life justification gap

Addressing Increased Impurities in Extended Product Shelf-Life: A Comprehensive Investigation Guide In the pharmaceutical manufacturing landscape, the integrity of product quality during shelf-life extension poses significant challenges. An increase in…

Assay degradation trend after market storage – CAPA and shelf-life justification gap

Addressing Assay Degradation Trends Post-Market Storage: An Investigation Approach In the pharmaceutical industry, ensuring product integrity throughout its shelf life is paramount. Recently, there have been reported concerns regarding assay…

Preservative loss at long-term stability – regulatory inspection risk

Understanding Preservative Loss During Long-Term Stability and Its Regulatory Implications In today’s highly regulated pharmaceutical environment, any deviation from expected product stability can trigger significant concerns, particularly when it relates…

Discoloration on stability at long-term stability – regulatory inspection risk

Assessing Discoloration During Long-Term Stability: A Guide for Regulatory Compliance In pharmaceutical manufacturing, discoloration observed during stability testing is a critical concern that may lead to significant regulatory scrutiny. Discoloration…

Preservative loss at accelerated conditions – regulatory inspection risk

Investigation of Preservative Loss at Accelerated Conditions and Its Impact on Regulatory Inspections In the pharmaceutical manufacturing landscape, preservative loss at accelerated conditions poses significant risks to product stability and…

Dissolution slowdown at accelerated conditions – CAPA and shelf-life justification gap

Dissolution Slowdown in Accelerated Conditions: Investigation and CAPA Approach In the realm of pharmaceutical manufacturing, a common challenge that can arise is the dissolution slowdown of products tested under accelerated…